Evidence map›Paper›PMID 36341454›Full record

ArticleFrontiers in immunology2022

Corrigendum: Malnutrition leads to increased inflammation and expression of tuberculosis risk signatures in recently exposed household contacts of pulmonary tuberculosis.

Arthur VanValkenburg, Vaishnavi Kaipilyawar, Sonali Sarkar, Subitha Lakshminarayanan, Chelsie Cintron, Senbagavalli Prakash Babu, Selby Knudsen, Noyal Mariya Joseph, C Robert Horsburgh, Pranay Sinha and 5 more

Open access · goldAbstract readPublished Erratum
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Arthur VanValkenburgDivision of Computational Biomedicine, Boston University School of Medicine, Boston, MA, United States.
Vaishnavi KaipilyawarDepartment of Medicine, Center for Emerging Pathogens, Rutgers-New Jersey Medical School, Newark, NJ, United States.
Sonali SarkarDepartment of Preventive and Social Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
Subitha LakshminarayananDepartment of Preventive and Social Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
Chelsie CintronDepartment of Medicine, Boston Medical Center, Boston, MA, United States.
Senbagavalli Prakash BabuDepartment of Preventive and Social Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
Selby KnudsenDepartment of Medicine, Boston Medical Center, Boston, MA, United States.
Noyal Mariya JosephDepartment of Microbiology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
C Robert HorsburghSection of Infectious Diseases, Boston University School of Medicine, Boston, MA, United States.
Pranay SinhaDepartment of Medicine, Boston Medical Center, Boston, MA, United States.
Jerrold J EllnerDepartment of Medicine, Center for Emerging Pathogens, Rutgers-New Jersey Medical School, Newark, NJ, United States.
Prakash Babu NarasimhanDepartment of Clinical Immunology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
William Evan JohnsonDivision of Computational Biomedicine, Boston University School of Medicine, Boston, MA, United States.
Natasha S HochbergDepartment of Medicine, Boston Medical Center, Boston, MA, United States.
Padmini SalgameDepartment of Medicine, Center for Emerging Pathogens, Rutgers-New Jersey Medical School, Newark, NJ, United States.
Jawaharlal Institute of Post Graduate Medical Education and Research · INBoston University · USBoston Medical Center · USRutgers New Jersey Medical School

Funding

Removing batch effects in high-throughput biomedical studiesR01GM127430 · NIGMS · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI William Evan Johnson · 2018 to 2026
$2.4M
Signature of profiling and staging the progression of TB from infection to disease.R21AI154387 · NIAID · BOSTON UNIVERSITY MEDICAL CAMPUS · PI JOHNSON, WILLIAM EVAN · 2020 to 2021
$468k
Microbiome-based biomarkers and models of lung cancer development and treatmentR21CA260382 · NCI · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI JOHNSON, WILLIAM EVAN, SEGRE, DANIEL · 2022 to 2023
$377k
NIAID NIH HHS R21 AI154387NIGMS NIH HHS R01 GM127430
6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fimmu.2022.1011166.].

Indexed as

immunoregulationinflammationmalnutritionTB biomarkerstuberculosis

Identifiers

PMID36341454
PMCPMC9632611
OpenAlexW4306923702

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.